We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPNT icon
101
SiriusPoint
SPNT
$2.68B
$1.1M 0.11%
+203,168
New +$1.22M
SMG icon
102
ScottsMiracle-Gro
SMG
$3.66B
$1.1M 0.11%
+13,915
New +$1.38M
LNC icon
103
Lincoln National
LNC
$8.81B
$1.09M 0.11%
23,321
+4,719
+25% +$269K
NTAP icon
104
NetApp
NTAP
$37.2B
$1.08M 0.1%
+16,551
New +$1.19M
BNY
105
Bank of New York Mellon
BNY
$107B
$1.08M 0.1%
25,787
-3,440
-12% -$153K
NTGR icon
106
NETGEAR
NTGR
$635M
$1.07M 0.1%
57,786
+41,574
+256% +$849K
VRSN icon
107
VeriSign
VRSN
$26.6B
$1.07M 0.1%
6,393
+4,496
+237% +$825K
DBC icon
108
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$1.07M 0.1%
+40,000
New +$1.12M
GEO icon
109
The GEO Group
GEO
$4.04B
$1.07M 0.1%
161,507
+127,780
+379% +$850K
CAH icon
110
Cardinal Health
CAH
$55.4B
$1.06M 0.1%
+20,370
New +$1.16M
GM icon
111
General Motors
GM
$76.8B
$1.06M 0.1%
33,517
+28,517
+570% +$1.07M
FN icon
112
Fabrinet
FN
$20.1B
$1.06M 0.1%
+13,059
New +$1.17M
NOV icon
113
NOV
NOV
$7B
$1.05M 0.1%
+62,307
New +$1.17M
OPTU
114
Optimum Communications Inc
OPTU
$301M
$1.05M 0.1%
+113,790
New +$1.19M
CE icon
115
Celanese
CE
$4.82B
$1.05M 0.1%
+8,945
New +$1.28M
AMED
116
DELISTED
Amedisys
AMED
$1.05M 0.1%
+9,962
New +$1.27M
JNJ icon
117
Johnson & Johnson
JNJ
$625B
$1.05M 0.1%
+5,890
New +$1.05M
FLG
118
Flagstar Bank National Association
FLG
$5.82B
$1.04M 0.1%
38,101
– –
LX
119
LexinFintech Holdings
LX
$241M
$1.04M 0.1%
464,389
+371,382
+399% +$859K
LH icon
120
Labcorp
LH
$25.9B
$1.03M 0.1%
+5,099
New +$1.09M
USNA icon
121
Usana Health Sciences
USNA
$286M
$1.02M 0.1%
14,159
+11,163
+373% +$831K
SYF icon
122
Synchrony
SYF
$25.6B
$1.02M 0.1%
36,804
-3,585
-9% -$124K
AGCO icon
123
AGCO
AGCO
$7.2B
$1.01M 0.1%
+10,288
New +$1.28M
RAD
124
DELISTED
Rite Aid Corporation
RAD
$1.01M 0.1%
+149,837
New +$992K
WTS icon
125
Watts Water Technologies
WTS
$13.1B
$1M 0.1%
8,185
– –
3 4
5
6 7

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.